Table 9.
L/N |
Absorption |
Distribution |
Metabolism |
Excretion |
Toxicity |
|||||
---|---|---|---|---|---|---|---|---|---|---|
Ligand no. | Lipophilicity | Intestinal absorption (human) Yes/No 75 %+ |
BBB permeability Yes/No | CNS Permeability (log PS) |
CYP3A4substrate (Yes/No) | CYP3A4 inhibitor (Yes/No) | Total Clearance(ml/min/kg) | Renal OCT2 substrate((Yes/No) | Max. Tolerated dose (human) mg/kg/day | Hepatotoxicity |
L-10 | 0.99 | 98.59 | −1.10 | −3.22 | Yes | No | −0.77 | No | −1.63 | No |
L-17 | 2.82 | 92.29 | −0.39 | −2.94 | No | Yes | 0.52 | No | 0.55 | No |
L-01 | 2.30 | 95.80 | 0.36 | −2.86 | No | No | 1.12 | No | 0.35 | No |
L-03 | 2.68 | 99.06 | 0.09 | −2.73 | No | No | 0.58 | No | 0.18 | No |
L-06 | 1.88 | 97.21 | 0.07 | −2.88 | No | No | 0.96 | No | 0.27 | No |
L-07 | 0.99 | 75.19 | 0.11 | −2.98 | No | No | 1.00 | No | 0.40 | No |
L-22 | 2.18 | 99.07 | 0.65 | −2.43 | Yes | No | 0.47 | Yes | 0.18 | No |
L-04 | 2.56 | 99.38 | 0.09 | −2.73 | No | No | 1.05 | No | 0.19 | No |
L-15 | 3.31 | 92.32 | −0.32 | −2.36 | Yes | Yes | 0.32 | No | 0.89 | No |
L-09 | 1.55 | 95.96 | −0.24 | −2.97 | No | No | 1.01 | No | 0.44 | No |
Note: Log P = High Lipophilicity (acceptance range: <5).